Risedronate is well-tolerated in postmenopausal women who are GI-intolerant to alendronate
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- May 1, 2001
has subject area
- 06 Biological Sciences (FoR)
- 09 Engineering (FoR)
- 11 Medical and Health Sciences (FoR)
- Endocrinology & Metabolism (Science Metrix)
published in
- Bone Journal